Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Stryker (SYK)

Stryker Q4 2025 sales rise 11.4% to $7.2 billion; 2026 EPS outlook $14.90 to $15.10

Positive Impact 3 of 5 earnings Written later

Stryker reported fourth-quarter 2025 net sales of $7.2 billion, up 11.4%, with reported diluted EPS of $2.20, up 56.0%, and adjusted EPS of $4.47, up 11.5%. For full-year 2025, net sales reached $25.1 billion and adjusted EPS was $13.63, and the company expects 2026 adjusted EPS of $14.90 to $15.10 and organic sales growth of 8.0% to 9.5%.

Key points

  • Q4 2025 reported net sales $7.2 billion, up 11.4%; organic growth 11.0%
  • Q4 reported diluted EPS $2.20 (up 56.0%), boosted by a $589 million tax benefit; adjusted EPS $4.47 (up 11.5%)
  • Full-year 2025 reported diluted EPS $8.40 (up 8.2%); adjusted EPS $13.63 (up 11.8%)
  • 2026 outlook: organic net sales growth of 8.0% to 9.5% and adjusted EPS of $14.90 to $15.10

The filing

CompanyStryker (SYK)
Form8-K, current report
Filed with the SECJan 29, 2026, 4:11 PM ET
Accession number0000310764-26-000006

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.